Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 240 citing articles:

Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
Tommy Nyberg, Neil M. Ferguson, Sophie Nash, et al.
The Lancet (2022) Vol. 399, Iss. 10332, pp. 1303-1312
Open Access | Times Cited: 1150
T cell responses to SARS-CoV-2 spike cross-recognize Omicron
Roanne Keeton, Marius B. Tincho, Amkele Ngomti, et al.
Nature (2022) Vol. 603, Iss. 7901, pp. 488-492
Open Access | Times Cited: 536
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
Brian J. Willett, Joe Grove, Oscar A. MacLean, et al.
Nature Microbiology (2022) Vol. 7, Iss. 8, pp. 1161-1179
Open Access | Times Cited: 531
Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California
Joseph A. Lewnard, Vennis Hong, Manish M. Patel, et al.
Nature Medicine (2022) Vol. 28, Iss. 9, pp. 1933-1943
Open Access | Times Cited: 321
Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada
Ana Cecilia Ulloa, Sarah A. Buchan, Nick Daneman, et al.
JAMA (2022) Vol. 327, Iss. 13, pp. 1286-1286
Open Access | Times Cited: 282
Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
Ori Magen, Jacob Waxman, Maya Makov-Assif, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 17, pp. 1603-1614
Open Access | Times Cited: 268
Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas
Paul Christensen, Randall J. Olsen, Sheng Long, et al.
American Journal Of Pathology (2022) Vol. 192, Iss. 4, pp. 642-652
Open Access | Times Cited: 201
Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study
Peter Bager, Jan Wohlfahrt, Samir Bhatt, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 7, pp. 967-976
Open Access | Times Cited: 178
The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
Gary R. McLean, Jeremy P. Kamil, Benhur Lee, et al.
mBio (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 174
Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales
Utkarsh Agrawal, Stuart Bedston, Colin McCowan, et al.
The Lancet (2022) Vol. 400, Iss. 10360, pp. 1305-1320
Open Access | Times Cited: 173
The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism
Brian J. Willett, Joe Grove, Oscar A. MacLean, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 135
Comparison of outcomes from COVID infection in pediatric and adult patients before and after the emergence of Omicron
Lindsey Wang, Nathan A. Berger, David C. Kaelber, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 134
Advances in the Omicron variant development
Antonio Vitiello, Francesco Ferrara, Amogh Auti, et al.
Journal of Internal Medicine (2022) Vol. 292, Iss. 1, pp. 81-90
Open Access | Times Cited: 133
The outbreak of SARS‐CoV‐2 Omicron lineages, immune escape, and vaccine effectivity
Yongbing Zhou, Hui‐Lin Zhi, Yong Teng
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 132
Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: a prospective cohort study in Bristol, United Kingdom
Catherine Hyams, Robert Challen, Robin Marlow, et al.
The Lancet Regional Health - Europe (2022) Vol. 25, pp. 100556-100556
Open Access | Times Cited: 124
mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions
Paulina Kapłonek, Deniz Cizmeci, Stephanie Fischinger, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 645
Open Access | Times Cited: 122
Omicron variant Spike-specific antibody binding and Fc activity are preserved in recipients of mRNA or inactivated COVID-19 vaccines
Yannic C. Bartsch, Xin Tong, Jaewon Kang, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 642
Open Access | Times Cited: 113
The Emergence of Omicron: Challenging Times Are Here Again!
Tanu Singhal
The Indian Journal of Pediatrics (2022) Vol. 89, Iss. 5, pp. 490-496
Open Access | Times Cited: 99
Clinical outcomes associated with Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in southern California
Joseph A. Lewnard, Vennis Hong, Manish M. Patel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 81
Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022
Dirk Eggink, Stijn P. Andeweg, Harry Vennema, et al.
Eurosurveillance (2022) Vol. 27, Iss. 4
Open Access | Times Cited: 81
COVID infection severity in children under 5 years old before and after Omicron emergence in the US
Lindsey Wang, Nathan A. Berger, David C. Kaelber, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 77
Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated persons
Chrispin Chaguza, Andreas Coppi, Rebecca Earnest, et al.
Med (2022) Vol. 3, Iss. 5, pp. 325-334.e4
Open Access | Times Cited: 72
Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort study
Susana Monge, Ayelén Rojas‐Benedicto, Carmen Olmedo, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 9, pp. 1313-1320
Open Access | Times Cited: 72
Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England
Zachary H. Strasser, Noah Greifer, Aboozar Hadavand, et al.
JAMA Network Open (2022) Vol. 5, Iss. 10, pp. e2238354-e2238354
Open Access | Times Cited: 69
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Shanti Pather, Shabir A. Madhi, Benjamin J. Cowling, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 49
Page 1 - Next Page

Scroll to top